Thank you to everyone who participated in the 9th annual Amsterdam Immunogenicity and Tolerance Seminar! The day would not have been such a success without you. Check out these photos from the event.
A special thanks to the Seminar organizing committee: Corine Kruiswijk (Director, Translational Research, Intravacc), Christiane Gerke, PhD (Head of Vaccine Programs & Vaccine Innovation Development, Institut Pasteur), Marcel Hoefnagel (Senior Scientist/Assessor, College ter Beoordeling van Geneesmiddelen), Elly van Riet (Senior Scientist, TuBerculosis Vaccine Initiative), Annie De Groot, MD (CEO/CSO, EpiVax Inc.) and Brian Roberts, PhD (Scientific Director, Preclinical Immunology, EpiVax Inc.)
Are you interested in attending the 10th annual Amsterdam Immunogenicity and Tolerance Seminar in 2024? The date will be announced early next year, but in the meantime, sign up here and we’ll keep you in the loop!
The 9th Amsterdam Immunogenicity & Tolerance Seminar will take place on Friday, November 10th from 9:30AM – 7:30PM. All events (including a networking session with beer, wine & snacks!) will be located at the Hilton Apollolaan in Amsterdam.
About the Amsterdam Immunogenicity & Tolerance Seminar:
Now in its 9th year, the Amsterdam Immunogenicity & Tolerance Seminar has become a much-anticipated forum for sharing research and ideas in the fields of immunogenicity and tolerance. Academic and industry research has progressed significantly in the past several years. Traditional protein therapeutics research has expanded in complexity to include Bispecific and Multispecifc antibodies, fusion proteins, and peptide therapeutics. All these exciting developments have generated many questions and added complexity for immunologists, drug developers and medical practitioners working to deliver safe and effective therapies.
Please note, this is an in-person event with no option for virtual attendance.
Check out past year’s AIT Seminars:
2022 Amsterdam Immunogenicity & Tolerance Seminar
2021 Amsterdam Immunogenicity & Tolerance Seminar
2019 Amsterdam Immunogenicity & Tolerance Seminar
Register Now!
A special thanks to the AIT23 Organizing Committee:
Corine Kruiswijk (Director, Translational Research, Intravacc), Christiane Gerke, PhD (Head of Vaccine Programs & Vaccine Innovation Development, Institut Pasteur), Marcel Hoefnagel (Senior Scientist/Assessor, College ter Beoordeling van Geneesmiddelen), Elly van Riet (Senior Scientist, TuBerculosis Vaccine Initiative), Annie De Groot, MD (CEO/CSO, EpiVax Inc.) and Brian Roberts, PhD (Scientific Director, Preclinical Immunology, EpiVax Inc.),
Questions or suggestions? Contact EpiVax: info@epivax.com
COVID-19 Policy: The Amsterdam Immunogenicity and Tolerance Seminar will follow all Netherlands COVID-19 guidelines.